Exploring Intratumoral Immunotherapy in Melanoma and Other Malignancies
Jason Luke, MD, FACP, discusses promising clinical research around intratumoral immunotherapy.
Dr. Jason Luke on Advances in How Melanoma is Diagnosed
Jason J. Luke, MD, FACP, assistant professor of medicine, The University of Chicago, discusses the international MSLT-II trial, which looks at the possibility of less surgery for melanoma patients in the future.